The effect of steroid pretreatment of deceased organ donors on liver allograft function: A blinded randomized placebo-controlled trial

Journal of Hepatology

Volumn 56, Issue 6, 2012, Pages 1305-1309

  Amatschek, Stefan ^a,b   Wilflingseder, Julia ^a,b   Pones, Mario ^b   Kainz, Alexander ^a,b   Bodingbauer, Martin ^b   Mühlbacher, Ferdinand ^b   Langer, Robert M ^c   Gerlei, Zsuzsanna ^c   Oberbauer, Rainer ^a,b  

^a KH Elisabethinen   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Donor pretreatment; Early liver allograft function; Liver transplantation; Steroid

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; DEXAMETHASONE; METHYLPREDNISOLONE; PLACEBO; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; AUSTRIA; COLD ISCHEMIA; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HUNGARY; LIVER GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PREMEDICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ADRENAL CORTEX HORMONES; ADULT; AGED; FEMALE; GRAFT REJECTION; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84861202973     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.01.020     Document Type: Article

References (18)

1. EUROTRANSPLANT. Eurotransplant International Foundation Annual Report 2009, 2010. Available from: http://wwweurotransplantorg.
2. F.J. Fernandez-Merino, J. Nuno-Garza, P. Lopez-Hervas, A. Lopez-Buenadicha, Y. Quijano-Collazo, and E. Vicente-Lopez Donor age as a risk factor for patient survival in the liver transplant Transplant Proc 35 2003 1795 1797 (Pubitemid 37093714)
3. R.W. Busuttil, and K. Tanaka The utility of marginal donors in liver transplantation Liver Transpl 9 2003 651 663 (Pubitemid 36874450)
4. S. Hariharan, C.P. Johnson, B.A. Bresnahan, S.E. Taranto, M.J. McIntosh, and D. Stablein Improved graft survival after renal transplantation in the United States, 1988 to 1996 N Engl J Med 342 2000 605 612 (Pubitemid 30118412)
5. P.I. Terasaki, J.M. Cecka, D.W. Gjertson, and S. Takemoto High survival rates of kidney transplants from spousal and living unrelated donors N Engl J Med 333 1995 333 336
6. M. Kusaka, J. Pratschke, M.J. Wilhelm, F. Ziai, K. Zandi-Nejad, and H.S. Mackenzie Activation of inflammatory mediators in rat renal isografts by donor brain death Transplantation 69 2000 405 410 (Pubitemid 30118123)
7. J. Pratschke, P. Neuhaus, and S.G. Tullius What can be learned from brain-death models? Transpl Int 18 2005 15 21 (Pubitemid 41742940)
8. J. Pratschke, M.J. Wilhelm, M. Kusaka, M. Basker, D.K. Cooper, and W.W. Hancock Brain death and its influence on donor organ quality and outcome after transplantation Transplantation 67 1999 343 348 (Pubitemid 29094001)
9. J.A. van der Hoeven, R.J. Ploeg, F. Postema, I. Molema, P. de Vos, and A.R. Girbes Induction of organ dysfunction and up-regulation of inflammatory markers in the liver and kidneys of hypotensive brain dead rats: a model to study marginal organ donors Transplantation 68 1999 1884 1890 (Pubitemid 30027342)
10. S. Weiss, K. Kotsch, M. Francuski, A. Reutzel-Selke, L. Mantouvalou, and R. Klemz Brain death activates donor organs and is associated with a worse I/R injury after liver transplantation Am J Transplant 7 2007 1584 1593 (Pubitemid 46776248)
11. P. Hauser, C. Schwarz, C. Mitterbauer, H.M. Regele, F. Muhlbacher, and G. Mayer Genome-wide gene-expression patterns of donor kidney biopsies distinguish primary allograft function Lab Invest 84 2004 353 361 (Pubitemid 41656490)
12. A. Kainz, J. Wilflingseder, C. Mitterbauer, M. Haller, C. Burghuber, and P. Perco Steroid pretreatment of organ donors to prevent postischemic renal allograft failure: a randomized, controlled trial Ann Intern Med 153 2010 222 230
13. K. Kotsch, F. Ulrich, A. Reutzel-Selke, A. Pascher, W. Faber, and P. Warnick Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: a prospective randomized controlled trial Ann Surg 248 2008 1042 1050
14. C. Miki, B.K. Gunson, J.A. Buckels, K. Uchida, Y. Mohri, and M. Kusunoki Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation Ann Surg 250 2009 502 503 author reply 503-504
15. J. Wilflingseder, A. Kainz, I. Muhlberger, P. Perco, R. Langer, and I. Kristo Impaired metabolism in donor kidney grafts after steroid pretreatment Transpl Int 23 2010 796 804
16. T. Lund, B. Fosby, O. Korsgren, H. Scholz, and A. Foss Glucocorticoids reduce pro-inflammatory cytokines and tissue factor in vitro and improve function of transplanted human islets in vivo Transpl Int 21 2008 669 678 (Pubitemid 351852766)
17. A.W. Ansari, R.E. Schmidt, and H. Heiken Prednisolone mediated suppression of HIV-1 viral load strongly correlates with C-C chemokine CCL2: in vivo and in vitro findings Clin Immunol 125 2007 1 4 (Pubitemid 47374541)
18. N.R. Fruhauf, C.L. Fischer-Frohlich, M. Kutschmann, I. Schmidtmann, and G. Kirste Joint impact of donor and recipient parameters on the outcome of liver transplantation in Germany Transplantation 92 2011 1378 1384